Professionisti del settore sanitario

Resolute Onyx

Drug-Eluting Stent

Expanding PCI Treatment Options for your Patients

Resolute Onyx™ DES is an advanced coronary stent that expands treatment options for complex cases.

Product Details

4.5- and 5.0-mm stent sizes

For extra-large vessels including left main

  • Maintained structural strength
  • Minimum foreshortening 

2.0-mm stent sizes

For extra-small vessels and tight lesions:

  • Lowest crossing profile
  • 3.25-m MSID for tapered vessels 

Core Wire Technology 

 For complex cases: 

  • Exceptional deliverability
  • Enhanced radiopacity
  • Greater conformability and flexibility
  • Adaptability in bifurcations  

4.5- and 5.0-mm sizes — ideally suited for left main and large vessels

  • Maintained structural strength1
  • Minimum foreshortening1

2.0-mm stent sizes — designed for extra-small vessels and tight lesions

  • Lowest crossing profile3
  • 3.25-mm MSID for tapered vessels

Resolute Onyx™ DES incorporates a platinum iridium core with 2.6x density of cobalt shell, for improved radiopacity 

  1. Resolute Onyx™ DES 2.0 X 26mm 
Continuous Sinusoid Technology

Core Wire Technology 

for optimal treatment of complex cases, including coronary bifurcations

  • Exceptional deliverability3
  • Enhanced radiopacity1 and no compromise to radial or longitudinal strength
  • Greater conformability and flexibility2

Adaptability in coronary bifurcations

  • Open cell design expands for large-vessel sidebranch access1
  • Excellent flexibility and conformability contribute to superior strut appostition2
stents resolute-onyx sidebranch cell size

Resolute Onyx DES

4.5 mm x 18 mm

 synergy des sidebranch cell size

Synergy DES

4.0 mm x 20 mm

DES  4.0 mm x 18 mm

Xience Xpedition DES

4.0 mm x 18 mm

Core Wire Technology is an evolution of Continuous Sinusoid Technology — and only Resolute Onyx DES has it

Continuous Sinusoid Technology

Flexible stent platform for outstanding flexibility and conformability

Sinusoid- formed wire

Sinusoid Formed Wire

helical wrap

Helical Wrap

Laser-fused

Laser-fusion

Core Wire Technology

Thinner struts with enhanced stent visibility for accurate stent placement

  1. Cobalt alloy shell
  2. Platimun iridium core
Diagram of Resolute Onyx
 

Explore Continuous Sinusoid Technology - (00:47)

The most deliverable DES3—  for complex cases

11%
Thinner
STRUTS4

36%
More
PUSHABLE4

20%
More
DELIVERABLE4

 

See Resolute Onyx DES in action - (01:07)

See the advantages of 4.5- and 5.0-mm stent sizes in treating extra-large vessels
Maggiori informazioni Less information (see less)

Ready to learn more?

BioLinx™ biocompatible polymer — specifically designed for drug-eluting stents 

  • Same proven durable polymer as Resolute Integrity DES, with excellent safety as demonstrated in the Global RESOLUTE Clinical Program5
  • BIO-RESORT6 and TRANSFORM OCT7 showed no benefit of bioabsorbable polymer DES over durable polymer DES  

See the science behind the BioLinx polymer - (01:03)

A well-balanced delivery system1

  • Greater flexibility
  • A lower crossing profile
  • PowerTrac™ Technology enabling exceptional deliverability
  • Lubricated hydrophilic coating for reduced drag
  • Resilient hypotube for high shaft column strength
  • Enhanced balloon material improves nonminimal pressure and balloon compliance
  • Reduced catheter profile under the stent enables lower crossing profiles
  • Platinum iridium markers for reduces crossing profile 
A well balanced delivery system

Product Specifications

1

Based on bench test data. May not be indicative of clinical performance.

2

Third-party modeling and analysis. Data may not be indicative of clinical performance.

3

Based on bench test data vs. Promus Premier™* DES, Synergy™* II DES, Xience Xpedition™* DES, Xience Alpine™* DES, BioMatrix NeoFlex™* DES, Orsiro™* DES, Ultimaster™* DES, and Resolute Integrity™ DES. Bench test data on file at Medtronic. These tests and models may not be indicative of clinical performance.

4

Compared with 3.0 mm x 18 mm Resolute Integrity™ DES in benchtop testing. Data on file at Medtronic. May not be indicative of clinical performance.

5

Yeh et al. 5-year safety and efficacy of Resolute zotarolimus-eluting stent, JACC Cardiovascular Interventions. 2017;10:247–254.

6

Von Birgelen et al. Data presented at TCT 2016. Study not powered for stent thrombosis.

7

Guagliumi et al. Data presented at PCR 2016. Investigator-initiated study not funded by Medtronic.